Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Apoptosis
    (1)
  • Autophagy
    (1)
  • Bcr-Abl
    (1)
  • Src
    (1)
  • c-Kit
    (1)
  • Others
    (1)
TargetMol | Tags By ResearchField
  • Cancer
    (1)
  • Others
    (1)
Filter
Search Result
Results for "

302962-49-8

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    2
    TargetMol | All_Pathways
  • Reference Standards
    1
    TargetMol | Standard_Products
Dasatinib
BMS-354825
T1448302962-49-8
Dasatinib (BMS-354825) is an orally active, ATP-competitive tyrosine kinase inhibitor that targets Src and Bcr-Abl (Ki=16/30 pM), with antitumor activity, used in the treatment of leukemia and lymphoma.
  • $37
In Stock
Size
QTY
TargetMol | Citations Cited
Dasatinib (Standard)
TMSM-3449302962-49-8
Dasatinib (Standard) is a reference standard for research and analysis in studies involving Dasatinib. Dasatinib (BMS-354825) is a tyrosine kinase inhibitor that inhibits Src and Bcr-Abl (Ki=16/30 pM) and is orally active and ATP-competitive. Dasatinib has antitumor activity and is used in the treatment of leukemia and lymphoma.
  • $98
7-10 days
Size
QTY